Search research articles
Contact Us
Filters
Showing results (51-60 of 76) with videos related to
Page
of 8
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
February 25, 2000
Glutamine synthetase in experimental meningitis: increased ratio of the subunits 3 and 2 may indicate enhanced activity
A V Smirnov, H Tumani, S Henne, et al.
Fluids and Barriers of the CNS
|
May 29, 2026
Natural killer cells and regulatory T cells in aneurysmal subarachnoid hemorrhage in peripheral blood and cerebrospinal fluid - a pilot study
A Pfnür, A Bohnacker, L Dörfer, et al.
Neurology
|
December 1, 1994
Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: cICAM-1 is an indicator for relapse
P Rieckmann, S Martin, I Weichselbraun, et al.
Journal of Neuroimmunology
|
November 26, 2002
The macrophage activity marker sCD14 is increased in patients with multiple sclerosis and upregulated by interferon beta-1b
J Brettschneider, D Ecker, A Bitsch, et al.
Epilepsy Research
|
August 27, 1999
Cisternal S100 protein and neuron-specific enolase are elevated and site-specific markers in intractable temporal lobe epilepsy
B J Steinhoff, H Tumani, M Otto, et al.
European Journal of Neurology
|
June 14, 2008
MxA protein--an interferon beta biomarker in primary progressive multiple sclerosis patients
A Millonig, A Dressel, D Bahner, et al.
Molecular Diagnosis & Therapy
|
July 3, 2014
Effects of repeated intrathecal triamcinolone-acetonide application on cerebrospinal fluid biomarkers of axonal damage and glial activity in multiple sclerosis patients
P S Rommer, F Kamin, A Petzold, et al.
Acta Neurologica Scandinavica
|
November 6, 2004
Interferon beta-1b modulates serum sVCAM-1 levels in primary progressive multiple sclerosis
A Bitsch, D Bahner, C Wachter, et al.
European Journal of Neurology
|
November 17, 2009
A novel presenilin1 mutation (Q223R) associated with early onset Alzheimer's disease, dysarthria and spastic paraparesis and decreased Abeta levels in CSF
I Uttner, J Kirchheiner, H Tumani, et al.
Muscle & Nerve
|
June 18, 2009
CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain-Barré syndrome
A Petzold, J Brettschneider, K Jin, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 76) with videos related to
Sort By:
Page
of 8
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
February 25, 2000
Glutamine synthetase in experimental meningitis: increased ratio of the subunits 3 and 2 may indicate enhanced activity
A V Smirnov, H Tumani, S Henne, et al.
Fluids and Barriers of the CNS
|
May 29, 2026
Natural killer cells and regulatory T cells in aneurysmal subarachnoid hemorrhage in peripheral blood and cerebrospinal fluid - a pilot study
A Pfnür, A Bohnacker, L Dörfer, et al.
Neurology
|
December 1, 1994
Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: cICAM-1 is an indicator for relapse
P Rieckmann, S Martin, I Weichselbraun, et al.
Journal of Neuroimmunology
|
November 26, 2002
The macrophage activity marker sCD14 is increased in patients with multiple sclerosis and upregulated by interferon beta-1b
J Brettschneider, D Ecker, A Bitsch, et al.
Epilepsy Research
|
August 27, 1999
Cisternal S100 protein and neuron-specific enolase are elevated and site-specific markers in intractable temporal lobe epilepsy
B J Steinhoff, H Tumani, M Otto, et al.
European Journal of Neurology
|
June 14, 2008
MxA protein--an interferon beta biomarker in primary progressive multiple sclerosis patients
A Millonig, A Dressel, D Bahner, et al.
Molecular Diagnosis & Therapy
|
July 3, 2014
Effects of repeated intrathecal triamcinolone-acetonide application on cerebrospinal fluid biomarkers of axonal damage and glial activity in multiple sclerosis patients
P S Rommer, F Kamin, A Petzold, et al.
Acta Neurologica Scandinavica
|
November 6, 2004
Interferon beta-1b modulates serum sVCAM-1 levels in primary progressive multiple sclerosis
A Bitsch, D Bahner, C Wachter, et al.
European Journal of Neurology
|
November 17, 2009
A novel presenilin1 mutation (Q223R) associated with early onset Alzheimer's disease, dysarthria and spastic paraparesis and decreased Abeta levels in CSF
I Uttner, J Kirchheiner, H Tumani, et al.
Muscle & Nerve
|
June 18, 2009
CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain-Barré syndrome
A Petzold, J Brettschneider, K Jin, et al.
Page
of 8